Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Aleafia Health Inc ALEAF

Aleafia Health Inc. is a Canada-based cannabis company. The Company offers cannabis products in Canada and destined for international markets, including Australia and Germany. The Company operates a virtual medical cannabis clinic staffed by physicians and nurse practitioners, which provide health and wellness services across Canada. It owns three licensed cannabis production facilities and operates a located distribution center all in the province of Ontario, including an outdoor cannabis cultivation facility in Canada. The Company produces a diverse portfolio of cannabis and cannabis derivative products, including dried flower, pre-roll, milled, vapes, oils, capsules, edibles, sublingual strips, and topicals, for sale in Canada in the medical and adult-use markets, and in select international jurisdictions. Its subsidiaries include Aleafia Inc., Canabo Medical Corporation, Aleafia Farms Inc., Emblem Corp., Emblem Cannabis Corporation, GrowWise Health Limited and other.


GREY:ALEAF - Post by User

Comment by Francoicon Mar 24, 2021 11:36am
144 Views
Post# 32866429

RE:RE:RE:RE:???????????? NO BUYING & NO VOLUME ???????????

RE:RE:RE:RE:???????????? NO BUYING & NO VOLUME ???????????

Totally agree!

Toweringmars wrote:

mmm, might be a little risky of a move. But frankly if this is the case I think we're looking at more than a 3-400m buyout. Quite possibly an all share deal, but that would put our valuations low. If they clean the books and get everything purdy then I'm thinking more along the lines of 2-2.50/share which would put the aquisition around 600 - 700mil. Its only makes sense considering the other valuations out there on companies that arent leaps and bounds further than we are. And none of those other companies are boasting 0.10/g gram outdoor costs and a large scale extraction facility, let alone EU-GMP which is en route.

Seems the MM's have put in a floor and keep moving that pending the pressure put on by the market. A little discouraging heading into THE best quarter we'll put out so far, but more buying opp for those with the stomach to handle the volatility. Once the market turns around again it could be a massive payday. 

 

 

CMHarring218431 wrote: Could a prospective buyer be responsible for a least some of the downward pressure since that last decent spike. They could have accumulated enough to then just sell enough to keep it where it is. If AH had moved up to $2.00+/-, the lower end of a buyout would be 3-4 hundred million dollars more. So why not?

 

 



<< Previous
Bullboard Posts
Next >>